14 Dec 2022
PME Excelência '21
After having our SME Lider status renovated in 2022, OWLPHARMA was awarded the PME Excelência ’21 (SME Excelence) status by IAPMEI. This award acknowledges companies, amongst the SME Lider status companies, for their merit and contribution to the national economy.
22 Nov 2022
Estamos a contratar!
A Owlpharma abriu 9 vagas para recrutamento. A informação encontra-se no documento anexado!
29 Aug 2022
Annex 1 - Manufacture of Sterile Medicinal Products
Later last week, the new Annex 1 “Manufacture of Sterile Medicinal Products” has been published and our team has scrutinized the new guidance and their main changes.
3 Jun 2022
Projectos financiados co-financiados por Fundos Sociais Europeus
A Owlpharma terminou recentemente os projetos co-financiados pelo Centro2020, Portugal2020 e pela União Europeia.
20 Apr 2022
France legalizes medical cannabis cultivation
On February 18th it was announced in the “Journal official de la République française” that as of March 1st it is legal to cultivate cannabis for medical purposes in France.
14 Apr 2022
Update: Available Audit Reports and Planned Audits
Our list of available audit reports and planned reports has been updated on our website!